These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 2938852)

  • 21. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
    Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
    Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside.
    Sinici I; Yonekawa S; Tkachyova I; Gray SJ; Samulski RJ; Wakarchuk W; Mark BL; Mahuran DJ
    PLoS One; 2013; 8(3):e57908. PubMed ID: 23483939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
    Meier EM; Schwarzmann G; Fürst W; Sandhoff K
    J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel.
    Ishikawa Y; Li SC; Wood PA; Li YT
    J Neurochem; 1987 Mar; 48(3):860-4. PubMed ID: 2949061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
    Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
    Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A; Conzelmann E; Sandhoff K
    Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemistry and genetics of gangliosidoses.
    Sandhoff K; Christomanou H
    Hum Genet; 1979; 50(2):107-43. PubMed ID: 116955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS; Krasnopol'skaia KD
    Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biochemical basis of gangliosidoses.
    Sandhoff K; Conzelmann E
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
    Li SC; Serizawa S; Li YT; Nakamura K; Handa S
    J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization.
    Banerjee A; Burg J; Conzelmann E; Carroll M; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1984 Mar; 365(3):347-56. PubMed ID: 6724528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y; Li YT; Li SC
    J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
    J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canine GM2-gangliosidosis: chemical and enzymatic features.
    Eto Y; Autilio-Gambetti L; McGrath JT
    Adv Exp Med Biol; 1984; 174():431-40. PubMed ID: 6234761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
    Kodama T; Togawa T; Tsukimura T; Kawashima I; Matsuoka K; Kitakaze K; Tsuji D; Itoh K; Ishida Y; Suzuki M; Suzuki T; Sakuraba H
    PLoS One; 2011; 6(12):e29074. PubMed ID: 22205997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
    Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
    Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.